Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
Article in Scientific Reports (November 2023)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Scientific Reports (November 2023)
Article in Journal of Hematology & Oncology (July 2023)
Article in Experimental Hematology & Oncology (September 2022)